Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents.
Selective visualization of cyclooxygenase-2 in inflammation and cancer by targeted fluorescent imaging agents.
复制标题
DOI:
10.1158/0008-5472.can-09-2664
复制
发表时间:
2010-05-01
期刊:
影响因子:
11.2
通讯作者:
Marnett LJ
中科院分区:
文献类型:
--
作者:
Uddin MJ;Crews BC;Blobaum AL;Kingsley PJ;Gorden DL;McIntyre JO;Matrisian LM;Subbaramaiah K;Dannenberg AJ;Piston DW;Marnett LJ
Effective diagnosis of inflammation and cancer by molecular imaging is challenging because of interference from non-selective accumulation of the contrast agents in normal tissues. Here we report a series of novel fluorescence imaging agents that efficiently target cyclooxygenase-2 (COX-2), which is normally absent from cells, but is found at high levels in inflammatory lesions, and in many premalignant and malignant tumors. After either intraperitoneal or intravenous injection, these reagents become highly enriched in inflamed or tumor tissue compared to normal tissue and this accumulation provides sufficient signal for in vivo fluorescence imaging. Further, we show that only the intact parent compound is found in the region of interest. COX-2-specific delivery was unambiguously confirmed using animals bearing targeted deletions of COX-2 and by blocking the COX-2 active site with high affinity inhibitors in both in vitro and in vivo models. Because of their high specificity, contrast, and detectability, these COX-2 beacons are ideal candidates for detection of inflammatory lesions or early-stage COX-2-expressing human cancers, such as those in the esophagus, oropharynx, and colon.